Metlife (MET) Other financing activities (2009 - 2026)

Metlife's Other financing activities history runs 18 years deep, the most recent figure standing at -$67.0 million for Q1 2026.

• On a quarterly basis, Other financing activities rose 66.33% year-over-year to -$67.0 million in Q1 2026; TTM through Mar 2026 was -$129.0 million, a 304.76% decrease from a year earlier, with the FY2025 full-year figure at -$261.0 million, down 217.04% from the prior year.
• Other financing activities eased to -$67.0 million in Q1 2026 per MET's latest filing, from -$46.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $166.0 million in Q2 2024 and bottomed at -$199.0 million in Q1 2025.
• The 5-year median for Other financing activities is -$32.0 million (2025), against an average of -$28.2 million.
• Across the five-year window, Other financing activities plunged 1600.0% in 2022 and jumped 388.24% in 2024, its largest moves.
• Year by year, Other financing activities stood at -$30.0 million in 2022, then plunged by 40.0% to -$42.0 million in 2023, then soared by 297.62% to $83.0 million in 2024, then sank by 155.42% to -$46.0 million in 2025, then slumped by 45.65% to -$67.0 million in 2026.
• Per Business Quant, the three latest MET Other financing activities figures stand at -$67.0 million (Q1 2026), -$46.0 million (Q4 2025), and $16.0 million (Q3 2025).